Jvion Revenue and Competitors
Estimated Revenue & Valuation
- Jvion's estimated annual revenue is currently $1.8M per year.
- Jvion received $Undisclosed in venture funding in January 2019.
- Jvion's estimated revenue per employee is $70,000
- Jvion's total funding is $8.9M.
Employee Data
- Jvion has 26 Employees.
- Jvion grew their employee count by 0% last year.
Jvion's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Technology | Reveal Email/Phone |
2 | VP Customer Success | Reveal Email/Phone |
3 | SVP, Partner Strategy | Reveal Email/Phone |
4 | Senior Director, Clinical Product | Reveal Email/Phone |
5 | Senior Director, Growth Enablement | Reveal Email/Phone |
6 | Director, Data Platform | Reveal Email/Phone |
7 | Chief Medical Information Officer | Reveal Email/Phone |
8 | Data Scientist | Reveal Email/Phone |
9 | Senior Director Clinical Development | Reveal Email/Phone |
10 | Data Scientist | Reveal Email/Phone |
Jvion Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $153.5M | 949 | 17% | N/A | $2.1B |
#2 | $53.2M | 179 | N/A | N/A | N/A |
#3 | $70.4M | 402 | N/A | N/A | N/A |
#4 | $2.4M | 15 | N/A | N/A | N/A |
#5 | $5.4M | 59 | N/A | N/A | N/A |
#6 | $1M | 16 | -57% | $18.6M | N/A |
#7 | $0.5M | 7 | N/A | N/A | N/A |
#8 | $1.9M | 33 | N/A | N/A | N/A |
#9 | $2M | 20 | N/A | N/A | N/A |
#10 | $9.5M | 73 | N/A | N/A | N/A |
#11 | $46.6M | 157 | 11% | N/A | N/A |
#12 | $75M | 422 | -10% | $114M | N/A |
#13 | $1.9M | 33 | N/A | N/A | N/A |
#14 | $3.8M | 33 | N/A | N/A | N/A |
#15 | $129.7M | 494 | N/A | N/A | N/A |
#16 | $5.2M | 45 | 0% | N/A | N/A |
#17 | $6.5M | 30 | N/A | N/A | N/A |
#18 | $13.5M | 93 | N/A | N/A | N/A |
#19 | $7.7M | 61 | 11% | N/A | N/A |
#20 | $42.5M | 143 | N/A | N/A | N/A |
What Is Jvion?
Jvion's Cognitive Clinical Success Machine helps providers take the patient-specific actions that will improve health. Using its underlying Eigen Sphere engine, the machine goes beyond risk stratification to identify the factors (clinical and non-clinical) driving patient risk andmost importantlythe personalized, recommended actions that will change a patient's risk trajectory. The machine tells you if you can do something about a patient's risk and, if so, what to do to change the outcome. As a result, providers are better able to effectively and positively impact more patient lives, individualize interventions, and focus time and the right resources to the exact patients who need them.
keywords:Enterprise Software,Health It,Healthcare,Pharmaceuticals$8.9M
Total Funding
26
Number of Employees
$1.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Jvion News
... Market Size, Outlook And Forecast | IBM, Microsoft, Enlitic, Arterys, Atomwise, Freenome, Butterfly Network, Jvion, Apixio, Ayasdi.
Jvion's flagship clinical intelligence system, the Jvion CORE, will integrate into NTT Data's Nucleus for Healthcare platform.
What You Should Know: NTT Data and Jvion have just announced a new partnership, which will bring Jvion's prescriptive intelligence...
2022 will be the year of bold action to address social determinants of health, and clinical AI will play a starring role in both understanding how these barriers drive disparities and directing the right resources to the right patients and populations. ATLANTA (PRWEB) November 22, 2021 Jvion, ...
ATLANTA (PRWEB) September 09, 2021 Jvion, a leader in prescriptive analytics, has continued its growth in 2021 with new integrations and partnerships, peer-reviewed results, and social determinants of health solutions designed to help healthcare organizations manage patient populations holistic ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 26 | -26% | N/A |
#2 | $2150M | 27 | 4% | N/A |
#3 | $6.1M | 27 | N/A | N/A |
#4 | N/A | 28 | 33% | N/A |
#5 | $5.3M | 28 | -3% | N/A |
Jvion Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2016-03-11 | $8.9M | Undisclosed | Article | |
2019-01-04 | $Undisclosed | Undisclosed | JMI Equity | Article |